行情

NSPR

NSPR

Inspiremd
NASDAQ
1.330
-0.041
-2.99%
盘后: 1.340 +0.01 +0.75% 18:31 10/06 EDT
开盘
1.400
昨收
1.371
最高
1.412
最低
1.200
成交量
7.02万
成交额
0
52周最高
4.650
52周最低
1.200
市值
1,106.99万
市盈率(TTM)
-0.5993
分时
5日
1月
3月
1年
5年
InspireMD,NAMSA 进入外包合作伙伴关系
InspireMD,NAMSA 进入外包合作伙伴关系
MT Newswires · 09/08 10:45
NSPR 简况
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

微牛提供InspireMD Inc(NASDAQ-NSPR)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NSPR股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NSPR股票基本功能。